Epithelica GmbH

📍 Berlin, Germany🗓 Founded 2025👥 4 employees
Biotechnology Research🌐 epithelica.com
Website LinkedIn
Epithelica is a Berlin-based biotech developing local, non-invasive gene-editing therapies for rare and underserved skin diseases. Built on pioneering research from the Hedtrich Lab, our lipid nanoparticle and RNA-based base-editing platform is designed to correct disease-causing mutations directly in the skin, offering durable, clinic-ready treatments without viral vectors. Our vision is simple: no skin disease is too rare to deserve a precise, scalable, and truly disease-modifying therapy.
0
Total investors
0
Early stage
0
Mid stage
0
Late stage
2025
Founded

Investors

0 investors
All
Early stage
Mid stage
Late stage
No investors in this category
Frequently asked questions
When was Epithelica GmbH founded?
Epithelica GmbH was founded in 2025.
What industry is Epithelica GmbH in?
Epithelica GmbH operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Epithelica GmbH based?
Epithelica GmbH is headquartered in Berlin, Germany.